Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Finnegan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2018
Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapyClaire L McGrory, Karen M Ryan, Erik Kolshus, et al.
The Journal of ECT|December 12, 2018
Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot TrialMartha Finnegan, Toni Galligan, Karen Ryan, et al.
The Journal of ECT|January 12, 2018
Towards International Standards: East Meets WestMartha Finnegan, Huseyin Bayazit, Thomas Cronin, et al.
Schizophrenia Research|March 21, 2016
Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS)Sami Omer, Martha Finnegan, Dennis G Pringle, et al.
Brain Sciences|August 29, 2024
Clinical, Cortical, Subcortical, and White Matter Features of Right Temporal Variant FTDJana Kleinerova, Mary Clare McKenna, Martha Finnegan, et al.
Psychological Medicine|April 10, 2025
Why is electroconvulsive therapy for depression more effective in older age? A causal mediation analysisAna Jelovac, Sabine Landau, Petros Beeley, et al.
The International Journal of Neuropsychopharmacology|May 11, 2026
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in IrelandJohn R Kelly, Christopher Sheridan, Patricia Iusan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2018
Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapyClaire L McGrory, Karen M Ryan, Erik Kolshus, et al.
The Journal of ECT|December 12, 2018
Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot TrialMartha Finnegan, Toni Galligan, Karen Ryan, et al.
The Journal of ECT|January 12, 2018
Towards International Standards: East Meets WestMartha Finnegan, Huseyin Bayazit, Thomas Cronin, et al.
Schizophrenia Research|March 21, 2016
Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS)Sami Omer, Martha Finnegan, Dennis G Pringle, et al.
Brain Sciences|August 29, 2024
Clinical, Cortical, Subcortical, and White Matter Features of Right Temporal Variant FTDJana Kleinerova, Mary Clare McKenna, Martha Finnegan, et al.
Psychological Medicine|April 10, 2025
Why is electroconvulsive therapy for depression more effective in older age? A causal mediation analysisAna Jelovac, Sabine Landau, Petros Beeley, et al.
The International Journal of Neuropsychopharmacology|May 11, 2026
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in IrelandJohn R Kelly, Christopher Sheridan, Patricia Iusan, et al.
Pageof 2